PAD Patient Pathways: A PAD Awareness Virtual Summit

Click here to register for the virtual summit

Add to Calendar

FACULTY

KAREN BAUER, DNP, APRN-CNP, CWS 
Director of Wound Services 
Program Director of UTMC Wound and HBO Center 
UT Medical Center 
Toledo, Ohio

MARC P. BONACA, MD, MPH 
Professor of Medicine 
Director of Vascular Research 
University of Colorado School of Medicine 
Aurora, Colorado

ANAHITA DUA, MBCHB, MBA, MSC 
Director of the Vascular Lab 
Massachusetts General Hospital 
Boston, Massachusetts 
University of Colorado School of Medicine 
Aurora, Colorado

JOHN N. EVANS DPM 
Chief of Podiatry, Beaumont Hospital 
Dearborn, Michigan 
Private Practice 
Allen Park, Michigan

RYAN HEBERT, MHA, RT (R)
Chief Operating Officer
Cardiovascular Institute of the South
Houma, Louisiana

CONSTANTINO S. PEÑA, MD
Interventional Radiologist
Miami Vascular Specialists
Miami Cardiac & Vascular Institute
Miami, Florida

FADI A. SAAB, MD, FACC, FSCAI, FASE 
Chief Operating Officer, Director of Cardiology & Vascular Medicine Advanced Cardiac & Vascular Centers 
Grand Rapids, Michigan

CRAIG M. WALKER, MD 
Clinical Professor of Medicine 
Tulane Medical School Cardiovascular 
Institute of the South Tulane Medical School / LSU School Medicine 
Houma, Louisiana

PROVIDER STATEMENT

Provided by HMP Education, an HMP Global Company.

For questions regarding this educational activity, or to cancel your account, please call 609-371-1137 or email accreditation@hmpglobal.com.

INTENDED LEARNERS

This initiative is intended for clinicians who encounter and care for patients who have or are at risk of developing PAD, including primary care physicians, NPs, PAs, interventional cardiologists, interventional radiologists, vascular surgeons, wound care specialists, podiatrists, endocrinologists, nephrologists, diabetologists, pharmacists, nurses, cath lab technicians, and vascular technologists.

LEARNING OBJECTIVES

After participating in this activity, learners should be better able to:

• Identify risk factors for PAD that should prompt clinical investigation

• Describe recommended assessment and testing strategies for the diagnosis of PAD

• Review the mechanisms of action of antiplatelet and anticoagulation medications approved for the treatment of PAD

• Summarize the latest antithrombotic therapy clinical trial data

• Balance the benefit of reduction of ischemic events versus increased risk of bleeding events when individualizing antithrombotic therapy for the treatment of PAD

• Employ patient-centered care strategies to reduce the risk of MACE and MALE in patients with PAD

• Assess the most current PAD guidelines for relevant clinical disciplines

• Evaluate patient pathways by specialty

ACTIVITY OVERVIEW

To be eligible for credit, participants must complete the educational activity, complete the pre-test and complete the evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

Release Date: September 28, 2022
Expiration Date: October 26, 2022
Estimated Time to Complete: 3.00 hour

There is no fee associated with this activity.

HARDWARE/SOFTWARE REQUIREMENTS

The evaluation is accessible after the activity via a PC or Mac computer with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. 

CONTINUING EDUCATION

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

HMP Education designates this internet live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

This continuing nursing education internet live activity awards 3.00 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 3.00 contact hour. 

NURSE PRACTITIONERS

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME.

PHYSICIAN ASSISTANTS

HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet live activity is designated for 3.00 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

PODIATRISTS

HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this internet live activity for a maximum of 3.00 continuing education contact hour.

VASCULAR & INTERVENTIONAL RADIOGRAPHERS

PAD Patient Pathways: A PAD Awareness Virtual Summit taking place on September 28 from 4:00pm ET has been approved for 3.00 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
2. Any investigational, off-label, or non-FDA approved content or discussion

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:

1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

FACULTY

The faculty has reported the following:

Dr. Bauer: has disclosed no relevant financial relationship with any ineligible company (commercial interest).

Dr. Bonaca: has disclosed no relevant financial relationship with any ineligible company (commercial interest).

Dr. Dua: Educational Consultant—Abbott, Boston Scientific, Gore

Dr. Evans: Speakers' Bureau—Janssen Pharmaceutical

Mr. Hebert: Advisory Board—Boston Scientific, Philips, Pfizer

Dr. Peña: Speaker—Penumbra, Cook Medical, BD Bard, Shockwave

Dr. Saab: Consultant—BD, Boston Scientific, CSI, Medtronic, Philips, Terumo

Dr. Walker: has disclosed no relevant financial relationship with any ineligible company (commercial interest).

CLINICAL REVIEWER

J Peter Oettgen MD

Associate Professor of Medicine

Harvard Medical School

Beth Israel Deaconess Medical Center, Boston MA

Dr. Oettgen has disclosed no relevant financial relationship with any ineligible company (commercial interest).

PLANNING COMMITTEE

Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

HMP Education planners and staff include Samantha Conforti, Randy Robbin, Lacey Schmeidler and Andrea Zimmerman.

No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA STATEMENT

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.

GRIEVANCE POLICY

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.

COMMERCIAL SUPPORT

Supported by an independent educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC